Species-specific binding of CD4 to the beta 2 domain of major histocompatibility complex class II molecules

doi:10.1084/jem.175.4.925

This Article

	Full Text (PDF)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Vignali, D. A.
	Articles by Hammerling, G. J.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Vignali, D. A.
	Articles by Hammerling, G. J.


Social Bookmarking

	What's this?

ARTICLES

Species-specific binding of CD4 to the beta 2 domain of major histocompatibility complex class II molecules

DA Vignali, J Moreno, D Schiller and GJ Hammerling
Institute for Immunology and Genetics, German Cancer Research Center, Heidelberg.

Exon-shuffled constructs between mouse (IA beta b) and human (DR3 beta) class II beta chains were made to study the interaction sites between CD4 and major histocompatibility complex (MHC) class II molecules, and to determine whether a species barrier is involved. The overall structure and the peptide binding groove appeared to be unaffected by the exon shuffling procedure as determined by monoclonal antibody and peptide binding assays, respectively. While purified CD4+ BALB/c T cells responded strongly in a mixed leukocyte reaction to transfectants expressing the whole IA molecule, the response to IA molecules containing a DR beta 2 domain was substantially reduced. In addition, the presence of an IA beta 2 domain in DR failed to restore the weak xenoreactivity to the whole DR molecule. Similar observations were made with murine HEL-specific, IA alpha k beta b-restricted T cell hybridomas which responded significantly stronger to the whole compared with the exon-shuffled IA molecules. The involvement of CD4 in these differential responses was confirmed by the observation that CD4 loss variants responded to both molecules comparably, and transfection of CD4 into these cells restored the parental phenotype. In contrast, CD4 loss variants transfected with human CD4 responded equally to both the whole and the exon-shuffled molecules. Taken together, these data imply the existence of a partial species barrier, and suggest that CD4 interacts with the beta 2 domain of MHC class II molecules, probably in addition to other contact sites. Models for the interaction of CD4 with MHC class II molecules are presented.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?

This article has been cited by other articles:

Menges, P. R., Jenks, S. A., Bikoff, E. K., Friedmann, D. R., Knowlden, Z. A. G., Sant, A. J. (2008). An MHC Class II Restriction Bias in CD4 T Cell Responses toward I-A Is Altered to I-E in DM-Deficient Mice. J. Immunol. 180: 1619-1633 [Abstract] [Full Text]
Yahata, T., Ando, K., Nakamura, Y., Ueyama, Y., Shimamura, K., Tamaoki, N., Kato, S., Hotta, T. (2002). Functional Human T Lymphocyte Development from Cord Blood CD34+ Cells in Nonobese Diabetic/Shi-scid, IL-2 Receptor {gamma} Null Mice. J. Immunol. 169: 204-209 [Abstract] [Full Text]
Harding, S., Lipp, P., Alexander, D. R. (2002). A Therapeutic CD4 Monoclonal Antibody Inhibits TCR-{zeta} Chain Phosphorylation, {zeta}-Associated Protein of 70-kDa Tyr319 Phosphorylation, and TCR Internalization in Primary Human T Cells. J. Immunol. 169: 230-238 [Abstract] [Full Text]
Wang, J.-h., Meijers, R., Xiong, Y., Liu, J.-h., Sakihama, T., Zhang, R., Joachimiak, A., Reinherz, E. L. (2001). Crystal structure of the human CD4 N-terminal two-domain fragment complexed to a class II MHC molecule. Proc. Natl. Acad. Sci. USA 10.1073/pnas.191124098v1 [Abstract] [Full Text]
Vidal, K., Daniel, C., Hill, M., Littman, D. R., Allen, P. M. (1999). Differential Requirements for CD4 in TCR-Ligand Interactions. J. Immunol. 163: 4811-4818 [Abstract] [Full Text]
Pan, S., Trejo, T., Hansen, J., Smart, M., David, C. S. (1998). HLA-DR4 (DRB1*0401) Transgenic Mice Expressing an Altered CD4-Binding Site: Specificity and Magnitude of DR4-Restricted T Cell Response. J. Immunol. 161: 2925-2929 [Abstract] [Full Text]
Chapoval, S. P., Neeno, T., Krco, C. J., Marietta, E. V., Harders, J., David, C. S. (1998). HLA-DQ6 and HLA-DQ8 Transgenic Mice Respond to Ragweed Allergens and Recognize a Distinct Set of Epitopes on Short and Giant Ragweed Group 5 Antigens. J. Immunol. 161: 2032-2037 [Abstract] [Full Text]
Rosloniec1, E. F., Brand, D. D., Myers, L. K., Esaki, Y., Whittington, K. B., Zaller, D. M., Woods, A., Stuart, J. M., Kang, A. H. (1998). Induction of Autoimmune Arthritis in HLA-DR4 (DRB1*0401) Transgenic Mice by Immunization with Human and Bovine Type II Collagen. J. Immunol. 160: 2573-2578 [Abstract] [Full Text]
Rosloniec, E. F., Brand, D. D., Myers, L. K., Whittington, K. B., Gumanovskaya, M., Zaller, D. M., Woods, A., Altmann, D. M., Stuart, J. M., Kang, A. H. (1997). An HLA-DR1 Transgene Confers Susceptibility to Collagen-induced Arthritis Elicited with Human Type II Collagen. J. Exp. Med. 185: 1113-1122 [Abstract] [Full Text]
Wang, J.-h., Meijers, R., Xiong, Y., Liu, J.-h., Sakihama, T., Zhang, R., Joachimiak, A., Reinherz, E. L. (2001). Crystal structure of the human CD4 N-terminal two-domain fragment complexed to a class II MHC molecule. Proc. Natl. Acad. Sci. USA 98: 10799-10804 [Abstract] [Full Text]